BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8526091)

  • 1. New molecules on dendritic cells and their interactions with T lymphocytes.
    Hart DN; Starling GC; Egner W; Hock BD; McLellan AD; McKenzie JL; Williams LA; Simmons DL
    Adv Exp Med Biol; 1995; 378():351-4. PubMed ID: 8526091
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of CTLA-4 in the regulation and initiation of T-cell responses.
    Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
    Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.
    Hathcock KS; Hodes RJ
    Adv Immunol; 1996; 62():131-66. PubMed ID: 8781268
    [No Abstract]   [Full Text] [Related]  

  • 4. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
    Linsley PS; Ledbetter J; Peach R; Bajorath J
    Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
    [No Abstract]   [Full Text] [Related]  

  • 5. The complexities of T-cell co-stimulation: CD28 and beyond.
    Sperling AI; Bluestone JA
    Immunol Rev; 1996 Oct; 153():155-82. PubMed ID: 9010723
    [No Abstract]   [Full Text] [Related]  

  • 6. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
    van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
    Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
    [No Abstract]   [Full Text] [Related]  

  • 7. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 8. CTLA-4 and T cell activation.
    Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
    Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
    Lane P
    Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
    Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28, CTLA-4 and their ligands: who does what and to whom?
    Sansom DM
    Immunology; 2000 Oct; 101(2):169-77. PubMed ID: 11012769
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of autoimmunity by inhibition of T cell costimulation.
    Daikh DI; Wofsy D
    Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-cell interactions regulate dendritic cell-dependent HIV-1 production in CD4+ T lymphocytes.
    Pinchuk LM; Polacino PS; Agy MB; Klaus SJ; Clark EA
    Adv Exp Med Biol; 1995; 378():461-3. PubMed ID: 8526118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional significance of an additional ligand for CTLA-4.
    Lenschow DJ; Su GH; Zuckerman LA; Nabavi N; Jellis CL; Gray GS; Miller J; Bluestone JA
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11054-8. PubMed ID: 7504292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
    Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
    Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defect of the CTLA4-Ig ligands on tumor-infiltrating dendritic cells.
    Chaux P; Martin MS; Martin F
    Adv Exp Med Biol; 1995; 378():389-92. PubMed ID: 8526100
    [No Abstract]   [Full Text] [Related]  

  • 19. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation.
    Bosticardo M; Ariotti S; Losana G; Bernabei P; Forni G; Novelli F
    Eur J Immunol; 2001 Sep; 31(9):2829-38. PubMed ID: 11536182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K; Dalakas MC
    Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.